Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 25, 2002

View Archived Issues

Aviron now part of MedImmune, expanding pipeline

Clinical testing of potentially safer amlodipine isomer begins at Sepracor

Clarinex tablets now available in U.S. pharmacies for SAR

Eos and Pharmacopeia decide not to merge

Prous Science announces new internet publication --Drug R&D Backgrounders: Sepsis and Septic Shock

QUATRx: a new biopharmaceutical company focusing on drugs targeting nuclear receptors

Another milestone reached in Celera Genomics/Aventis collaboration on cathepsin S inhibitors

Prana completes clinical stage of phase II Alzheimer's trial

MVA-Muc1-IL-2 enters phase II trials in lung and breast cancers

Single-dose EPI-2010 reduces need for bronchodilator medication in asthma patients

Nabi and Cankat sign Nabi-HB distribution agreement for Turkish market

Antibody research collaboration signed by Xenerex and DNAX Research

Merck's European C225 program progresses as planned despite U.S. setback

Frovatriptan completes mutual recognition procedure for E.U.-wide approval

Pieris and CytoTools collaborate to discover human Anticalins for atherosclerosis

Patient enrollment completed in trial of G17DT in gastric cancer

FDA approval granted for Eligard 7.5 mg, formerly Leuprogel One-Month Depot

TransDerm Technologies and Virotek to develop rapid lead poisoning detection test

Cognishunt system enters pivotal trials in AD patients

Tubulin-binding agents from AstraZeneca with antiangiogenic activity

Pyrazolotriazolopyrimidine derivatives with use in neurological diseases

Peptides with affinity for erythropoietin receptors useful in neurodegenerative disorders

Novel TNF-alpha production inhibitors identified at Santen

Sepracor scientists synthesize the four diastereomers of a piperidinyl-containing propionamide

Cell adhesion inhibitors described in patent by Tanabe Seiyaku

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...